HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul Winner Selected Research

Dihydroergotamine (Agit)

1/2021STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD® ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul Winner Research Topics

Disease

30Migraine Disorders (Migraine)
03/2022 - 01/2002
10Headache (Headaches)
01/2017 - 01/2002
10Pain (Aches)
07/2016 - 01/2002
4Nausea
10/2006 - 01/2002
2Headache Disorders (Headache Syndromes)
05/2011 - 11/2003
2Dizziness (Lightheadedness)
03/2009 - 01/2002
2Respiratory Tract Infections (Respiratory Tract Infection)
03/2009 - 11/2005
2Paresthesia (Dysesthesia)
03/2009 - 11/2005
2Hyperacusis (Phonophobia)
11/2005 - 03/2003
2Photophobia (Light Sensitivity)
11/2005 - 03/2003
2Sleepiness
11/2005 - 01/2002
1Body Weight (Weight, Body)
04/2012
1Injection Site Reaction
10/2006
1Gastroenteritis
11/2005
1Anorexia
11/2005
1Epilepsy (Aura)
11/2005
1Vomiting
11/2005
1Tension-Type Headache (Tension Headache)
11/2003
1Primary Headache Disorders
11/2003
1Asthenia
01/2002
1Fatigue
01/2002

Drug/Important Bio-Agent (IBA)

8Pain-FreeIBA
07/2016 - 03/2003
6TabletsIBA
01/2012 - 10/2003
6Sumatriptan (Imigran)FDA LinkGeneric
10/2006 - 03/2003
5rizatriptan (Maxalt)FDA Link
04/2012 - 01/2002
4Tryptamines (Triptans)IBA
11/2017 - 07/2002
4Nasal SpraysIBA
07/2016 - 06/2005
4Topiramate (Topamax)FDA LinkGeneric
01/2012 - 11/2005
3erenumabIBA
01/2020 - 01/2017
3zolmitriptan (Zomig)FDA Link
07/2016 - 01/2006
2SodiumIBA
04/2015 - 01/2007
2sumatriptan-naproxenFDA Link
04/2015 - 01/2007
2eletriptan (Relpax)FDA Link
04/2007 - 03/2003
1eptinezumabIBA
03/2022
1Dihydroergotamine (Agit)FDA LinkGeneric
01/2021
1lasmiditanIBA
01/2021
1Opioid Analgesics (Opioids)IBA
11/2017
1Monoclonal AntibodiesIBA
01/2017
1Calcitonin Gene-Related PeptideIBA
01/2017
1Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
01/2017
1A-factor (Streptomyces)IBA
04/2012
1Type A Botulinum Toxins (Botox)FDA Link
10/2011
1preemptIBA
10/2011
1amsonic acid (DAS)IBA
05/2011
18-dehydroxythienamycin (NS 5)IBA
02/2006
1Acetaminophen (Paracetamol)FDA LinkGeneric
06/2005
1Ibuprofen (Motrin)FDA LinkGeneric
06/2005
1Botulinum Toxins (Botulinum Toxin)IBA
11/2003

Therapy/Procedure

5Therapeutics
01/2017 - 11/2003
5Aftercare (After-Treatment)
07/2016 - 10/2003
2Drug Therapy (Chemotherapy)
06/2005 - 11/2003
1Intravenous Administration
01/2021
1Contraindications
11/2003